Cogent Biosciences (COGT) Return on Assets (2018 - 2026)
Cogent Biosciences' Return on Assets history spans 9 years, with the latest figure at 0.0% for Q1 2026.
- Quarterly Return on Assets rose 1.0% to 0.0% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.0% through Mar 2026, up 1.0% year-over-year, with the annual reading at 0.01% for FY2025, 0.0% changed from the prior year.
- Return on Assets came in at 0.0% for Q1 2026, up from 0.0% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q3 2022 to a low of 0.01% in Q2 2025.
- The 5-year median for Return on Assets is 0.01% (2024), against an average of 0.01%.
- Year-over-year, Return on Assets decreased -1bps in 2025 and then rose 1bps in 2026.
- Cogent Biosciences' Return on Assets stood at 0.0% in 2022, then fell by -28bps to 0.01% in 2023, then decreased by -24bps to 0.01% in 2024, then soared by 35bps to 0.0% in 2025, then grew by 20bps to 0.0% in 2026.
- Per Business Quant, the three most recent readings for COGT's Return on Assets are 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025).